Summary.-The blood, spleen and liver of mice were examined by means of electron spin resonance (e.s.r.), throughout the course of myeloid leukaemia induced by intravenous injection of leukaemic spleen cells. In blood, marked increases in the concentrations of iron transferrin and ceruloplasmin occurred within the first 3 days after injection. In the spleen, changes in the concentrations of paramagnetic copper and iron complexes were detectable by about the 5th day, before any measurable splenic enlargement, whilst in the liver changes were detectable by about the 8th day. The changes occurring in blood, spleen and liver during the development of leukaemia appear to be related and they are discussed in terms of iron transport.
SINCE the first reported detection of e.s.r. signals from biological materials (Commoner, Townsend and Pake, 1954) there has been considerable interest in the differences between normal and neoplastic tissues. Differences have been demonstrated in both the free radical (e.g. Kent, 1966, 1969) and the paramagnetic metal (e.g. Nebert and Mason, 1963) content of tumours and the homologous normal tissues. However, there have been few studies of the systemic changes which occur during the development of malignancy (Vithayathil, Ternberg and Commoner, 1965; Saprin et al., 1966a, b, c; Driscoll et al., 1-967; Swartz et al., 1973) and with the exception of one of these (Swartz et al., 1973) they have been confined to free radical changes. The work reported below is part of a programme to study changes in both the free radicals and the paramagnetic metal species which occur during the development of experimental solid tumours and leukaemias. This paper deals primarily with changes in the paramagnetic metal species in the organs associated with development of a myeloid leukaemia in mice.
MATERIALS AND METHODS
Animals.-The mice were an RF/J strain from Okayama University Medical School, Okayama, Japan that had been maintained in the Paterson Laboratories for several years. They are now designated RF/Hi. A minimum of 6 female mice, 2-4 months old, were used for each experimental point and these were starved overnight before being killed.
Inductionl and pathology of the leulkaemia.-
The leukaemic line was induced (Tanaka, 1969; Tanaka and Craig, 1970) by whole body X-irradiation (400 rad, 300 kVp at 30-35 rad min-1) followed by an injection of a leukaemic organ filtrate prepared from RFM/Un nmice (Upton, Jenkins and Conklin, 1964) . After 5 5 months a mouse manifested marked hepatosplenomegaly with immature cells in the peripheral blood. The leukaemia was maintained and stabilized by serial passage of leukaemic cell suspensions. At this stage, an approximately six-fold increase in spleen weight was observed, accompanied by an increase in the peripheral blood leucocyte count from ,5 x 103 ud-l to 6 x 104 dl-1. Differential counts from blood smears taken at an advanced stage of leukaemia showed about 30% of a leukaemic myelomonocytic type of cell and about 5000 of lymphocytes. The disease was therefore shown to be a myeloid leukaemia (Tanaka, 1969) .
In the present experiments, leukaemia was induced by intravenous injection of approximately 106 leukaemic spleen cells. A typical curve of spleen weight against time after injection is shown in Fig. 1 and frozen into sinmilar icicles, care being taken to avoid the inclusion of air bubbles.
All samiples were stored at -196°C in sealed, plastic ampoules, until required for examination.
E.S.R. spectra.-The samples were examined at -196°C in a liquid nitrogen insert Dewar (Varian E-246) and spectra were recorded as the first derivative of the absorption, using a Varian E-9 spectrometer with 100 kHz modulation. Quiantitative measurements of peak height w,ere made by comparison with a standard of manganous chloride in zinc sulphide, in a dual cavity operating in the H014 mode. This conipensated for any changes in instrumental sensitivity with time. The incident microwave power was 5 mW, except during power saturation studies, and the mcdulation amplitude was 10 G. 
RESULTS

Blood
The e.s.r. spectrum of frozen blood (Fig. 2a) shows 3 major components at g values of approximately 6-0, 4'3 and 2*05. The broad signal at g 6-0 can be assigned principally to methaemoglobin (Peisach et al., 1971a) . The signal at g 4*3 is characteristic of Fe (III) in a rhombic field. From the positions of the 3 components it can be assigned unambiguously to iron transferrin (Aasa et al., 1963; Blumberg, 1967) in which the anion binding site is occupied by bicarbonate (Aisen et al., 1967) . The signal at g 2-05 is due to a Cu (II) complex.
Separation of blood showed that this signal was primarily in the plasma. Detailed examination of this signal showed the presence of hyperfine structure which was consistent with that of the copper g-value 6.0 4.3 containing protein, ceruloplasmin (Andreasson and Vanngard, 1970; Vanngard, 1974) . This assignment is confirmed by other workers (Mailer et al., 1974) . Two minor peaks are also detectable in the spectrum of mouse blood, at g values of 2-02 and 2-00 (Fig. 2b) . The latter is readily power saturated and can be assigned to free radicals. The signal at g 2-02 does not saturate so readily, but does show considerable saturation at 50 mW. The cause of this signal is at present unknown.
In a control experiment, blood samples from mice given an injection of 106 normal spleen cells showed no change in their e.s.r. spectra over a period of 11 days. In contrast, blood samples taken during the development of leukaemia showed marked changes in the concentrations of iron transferrin and ceruloplasmin 200G, ( Fig. 3) . The terminal stage of the disease, in which the iron transferrin level reaches values 2-3 times normal, was usually marked by haematuria.
The methaemoglobin signal at g 6 00 and the free radical signal at g showed no significant change throughout the course of the disease. However, a few samples of both normal and leukaemic blood gave elevated free radical signals. rhe magnitude of the small signal at g , 2-02 appeared to be increased between Days 5 and 7 but it is partially masked by the larger ceruloplasmin signal.
Spleen
The e.s.r. spectrum of normal mouse spleen, recorded at -196°C (Fig. 4) shows prominent signals at g values of approximately 6-0, 4 3, 2-04, 2-00 and 1-94. The signal at g -6 can be assigned to a high-spin ferric haem compound, possibly methaemoglobin, while the signal at g 4-3 is due to rhombic high-spin iron. The line width of this signal is only 50 G and it does not exhibit the characteristic structure of the iron-transferrin-bicarbonate complexin blood. However, it closely resembles the signal originally assigned to a binary complex of Fe (III) and transferrin (Aisen et al., 1967) but now shown to be a complex of citrate and iron, without (Price and Gibson, 1972) , or more probably with, transferrin (Aisen et al., 1973) . The uptake by transferrin of iron from the spleen is believed to involve the anion binding site of transferrin (Zschocke and Bezkorovainy, 1974) . The observed signal could arise from a species associated with this process. Microwave power saturation studies of the g = 2 region showed no saturation of the broad g-2-04 signal, the narrow g ' 2-00 signal or the signal at g 1-94. The g 2-04 signal is probably due to one or more copper complexes and the narrow g 2 00 signal to a flavin semiquinone free radical in the respiratory chain (Beinert and Palmer, 1965) . The signal at g 1-94 is probably due to low spin non-haem iron in an unusual ligand field that includes a sulphur atom (Hollocher, Solomon and Ragland, 1966) . This, like the g 2-00
signal, is located in mitochondria (Nebert and Mason, 1963; Mallard and Kent, 1969 (Fig. 6) . The signals at g values of 2-4, 2-25 and 1-91 can be assigned to cytochrome P450 (Peisach and Blumberg, 1970) . Microwave power saturation studies showed the g 2-00 signal to saturate readily, possibly indicating a major free radical component. The signals at g values of 2-03 and 1 97 also showed saturation at higher power (>20 mW). The signal at a g value of 1994 is similar to that observed in spleen and can be assigned to a mitochondrial low-spin iron complex (Hollocher et al., 1966; Mallard and Kent, 1969) . The signal at a g value of 1997 has been shown to arise from Mo(V) in a molybdoprotein of mitochondria (Peisach, Oltzik and Blumberg, 1971b) which is now believed to be the molybdohaemoprotein sulphite oxidase (Kessler et al., 1974) . Both these species may also contribute to the g 2-00
signal. The signal at g 2-03 is similar to that reported in the liver of carcinogen fed rats (Vithayathil et al., 1965) the liver of untreated rats (Commoner et al., 1970) and rabbits (Foster and Hutchison, 1974) , when sufficient nitrite was present in their diet. The signal has been assigned to an iron-NO complex with a thiol containing protein (Woolum, Tiezzi and Commoner, 1968) , which appears to originate in the intracellular fluid (Hutchison, Foster and Mallard, 1971) . The signals at g values of and 541 are similar to those observed in leukaemic spleen and can be assigned to catalase. The signal at g 4-3 is also similar to that in spleen and is produced by high-spin ferric iron in a rhombic (Tanaka, 1969) , splenic enlargement or detectable leukaemic infiltration of liver or spleen (Dodd and Giron-Conland, 1975) . The concentration of iron transferrin rises to a maximum, within 3 days of injection, (Swartz et al., 1973) . In this case iron transferrin was not examined. In human serum the concentration of iron transferrin appears to be generally decreased in cases of malignancy, including cancer of haematopoietic tissues (Hughes, 1972) . This is at variance with the present findings, although in the human studies no account is taken of possible changes in concentration of iron transferrin with the stage of the disease. Iron transferrin is reported to be decreased in iron deficiency anaemia and certain infections, whilst it is increased in haemolytic anaemia and haemorrhage (Owen, 1967) . A decrease in iron transferrin, with a concomitant increase in ceruloplasmin, has been demonstrated in e.s.r. studies of the blood of rats bearing a Yoshida sarcoma (Dodd, 1975) . Increases in serum concentrations of ceruloplasmin are widely reported in cases of human leukaemia, lymphoma and Hodgkin's disease (Warren et al., 1969; Hrgovcic et al., 1968 Hrgovcic et al., , 1973a Tessmer et al., 1972 Tessmer et al., , 1973a Jelliffe, 1973) and in other malignant diseases (Hughes, 1972) . Recently e.s.r. has been used to demonstrate similar increases in the blood of patients with Hodgkin's disease and with cancers of the breast (Foster et al., 1973) and to study the effects of radiotherapy on plasma ceruloplasmin concentrations in a variety of cancer patients (Swartz and Wiesner, 1972) . However, serum ceruloplasmin concentrations also increase during pregnancy, acute and chronic infections, collagen disorders and myocardial infarction, following surgery and after administration of oestrogens and thyroid and pituitary hormones (Hrgovcic et al., 1973c; Hughes, 1972; Owen, 1967) . Changes in the concentrations of individual plasma proteins are therefore not specific to leukaemia or even to malignant diseases, although some relationship appears to exist between the concentrations of ceruloplasmin and iron transferrin in blood. The nature of this relationship is influenced by the disease, e.g. a parallel relationship in myeloid leukaemia and an anti-parallel relationship in Yoshida sarcoma, and a study of this relationship may lead to a better understanding of the biochemistry of its de-velopment.
Ceruloplasmin transports copper through the body but a more important role may be its ferroxidase activity (Osaki, Johnson and Frieden, 1966; McDermott et al., 1968; Frieden, 1971 ). This appears tc be essential to the utilization of Fe(II) bv tranisferrin. Here therefore is a direct link between ceruloplasmin and iron transferrin.
In the myeloid leukaemia studied here, the increased uptake of iron by plasma, indicated by the initial increase in iron transferrin, is assisted by the concomitant increase in ceruloplasmini. The cause of this increase in iron uptake is at present unclear. It may result from increased haemoglobin catabolism. Since iron is also important in the mitotic process and since transferrin promotes the growth of lymphocytes (Tormey, Imrie and Mueller, 1972; , the increase in signal may be associated with the increase in white blood cells and growth of leukaemic cells in the spleen.
The role of transferrin is primarily the distribution of iron between organs taking part in iron metabolism (Zschocke aind Bezkorovainy, 1974 The terminal stage of leukaemia (Days 10 and 11) is marked by a massive increase in iron transferrin and a decrease in ceruloplasnmin in the blood. The former appears to be associated with haemorrhage, while the latter may be part of the general decline in activity associated with morbidity.
Parallel studies on wet tissues from these leukaemic mice (Dodd and GironConland, 1975) have shown changes in the concentration of ascorbyl radicals in spleen and liver during the development of leukaemia. The ascorbyl radical concentration in spleen reaches a maximum as the copper and iron signals decrease in magnitude. In liver the ascorbyl radical concentration increases as the signals at g values of 1-94, 2-00 and 2-25 decrease. Ceruloplasmin has been shown to exhibit ascorbate oxidase activity (Frieden, McDermott and Osaki, 1965) and, although not generally accepted (Aisen, 1974) it has been postulated that ascorbic acid is intimately involved in iron transport (Mazur, Green and Carleton, 1960; Osaki et al., 1966) . The increase in ascorbyl radical concentration in both spleen and liver might indicate reduction of Fe(III) to Fe(II) and possibly subsequent removal of iron from the tissues. The e.s.r. results indicate that the observed changes in organs of leukaemic mice may be inter-related, representing different aspects of iron transport. Much work is still necessary to identify all the species involved and to determine their site of action within the cell. It is believed that e.s.r. can, in future, help to elucidate some of the biochemical events involved in the development of malignant disease. A change in one particular biochemical species may have many different causes but simultaneous examination of several species may give specific information.
For example, changes in ceruloplasmin during the course of Hodgkin's disease have long found limited clinical application, but it now appears that simultaneous determination of ceruloplasmin and iron transferrin gives a more reliable guide to patient status (Foster, unpublished 
